Protocol summary

Study aim
Comparison of the effect of intravenous Atropine and topical Tetracaine in the occurrence of Cardio-Ocular Reflex (COR) in Strabismus surgery.
Design
A controlled, parallel-group, triple-blind, randomized, phase 3 clinical trial on 120 patients. The lottery was used for randomization.
Settings and conduct
This is a three-blind randomized clinical trial that was conducted on 120 patients who were candidates for Strabismus surgery in Faiz Hospital, Isfahan. After the approval of the ethics committee of the university, if the entry criteria were met, the patients (or their guardians) were included in the study and if they were satisfied, they were randomly assigned to the groups. In each group, the desired intervention was applied and the patient's clinical symptoms were recorded. The clinical caregiver evaluating the symptoms was different from the person applying the intervention and did not know the type of intervention. Even though the patients were included in the study, they were not aware of the type of intervention applied, so they were all blind. The data analysts also did not know the type of intervention applied in each group.
Participants/Inclusion and exclusion criteria
Inclusion criteria: patients 10 to 70 years old, candidates for Strabismus surgery, ASA anesthesia class I and II Non-entry criteria: medical sensitivity to Atropine, tetracaine, and artificial tears, history of cardiovascular diseases
Intervention groups
Intervention group A: Patients in this group received 0.5 mg of intravenous Atropine immediately after anesthesia. Intervention group B: Patients in this group received 3 to 5 drops of 0.5% Tetracaine in 4 directions on the eyeball immediately after anesthesia. Control group C: Patients in this group received 3 to 5 drops of artificial tears immediately after anesthesia.
Main outcome variables
Heart Rate; Blood Pressure

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20150106020588N8
Registration date: 2022-08-13, 1401/05/22
Registration timing: retrospective

Last update: 2022-08-13, 1401/05/22
Update count: 0
Registration date
2022-08-13, 1401/05/22
Registrant information
Name
Darioush Moradi Farsani
Name of organization / entity
Isfahan Univesity of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 31 3625 5555
Email address
dmoradi@med.mui.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2018-04-21, 1397/02/01
Expected recruitment end date
2019-04-21, 1398/02/01
Actual recruitment start date
2020-06-20, 1399/03/31
Actual recruitment end date
2021-05-21, 1400/02/31
Trial completion date
2021-05-23, 1400/03/02
Scientific title
Comparison of the effectiveness of preoperative administration of intravenous Atropine and topical Tetracaine on the incidence and severity of Oculo Cardiac Reflex (OCR) in strabismus surgery
Public title
Comparison of the effects of Atropine and Tetracaine on Oculo Cardiac Reflex (OCR) in strabismus surgery
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
Candidate for Strabismus surgery Age 10 to 70 years ASA class I and II informed consent to enter the study
Exclusion criteria:
Allergic to Atropine, Tetracaine and artificial tears Cardiovascular diseases history
Age
From 10 years old to 70 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 120
Actual sample size reached: 120
Randomization (investigator's opinion)
Randomized
Randomization description
This is a simple randomized clinical trial in which patients entered the study groups by lottery; The medicines and placebo were placed in sealed, opaque, and similar form packets which were coded. Each code was also written on a piece of paper, folded, and placed inside a box. After entering the operating room, each patient took one of the papers out of the box; The pocket with the same number was the intervention that was applied to him. This process continued till the number of patients reached the desired one.
Blinding (investigator's opinion)
Triple blinded
Blinding description
This is a triple-blind clinical trial; In this way, before obtaining consent, patients were informed about the study but didn't know which group they would be in and therefore were blind. Also, the researcher who recorded the patient's symptoms was different from the nurse who injected the drug and didn't know the type of drug and was blind. Analysts who analyzed the data collected during the study also didn't know the type of intervention applied in each group and were blind.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee in Biomedical Research, Isfahan University of Medical Sciences
Street address
Hezar Jarib
City
Isfahan
Province
Isfehan
Postal code
8174673461
Approval date
2020-06-11, 1399/03/22
Ethics committee reference number
IR.MUI.MED.REC.1399.332

Health conditions studied

1

Description of health condition studied
Strabismus
ICD-10 code
H50
ICD-10 code description
Other strabismus

Primary outcomes

1

Description
Heart Rate
Timepoint
Before induction, immediately after the induction of anesthesia and then every 5 minutes to 30 minutes, and then every 10 minutes until the end of the surgery
Method of measurement
ECG monitoring

2

Description
Blood Pressure
Timepoint
Before induction, immediately after the induction of anesthesia and then every 5 minutes to 30 minutes, and then every 10 minutes until the end of the surgery
Method of measurement
Sphygmomanometer

Secondary outcomes

1

Description
Surgery Duration
Timepoint
From the moment of surgical intervention to the end of eye dressing
Method of measurement
Timer

Intervention groups

1

Description
Intervention group 1: Patients in this group after inducting of anesthesia using 5 mg/kg of Thiopental sodium manufactured by Elixir Company, an amount of 0.5 mg/kg of Atracurium manufactured by Caspian Pharmaceutical Company, and the amount of 2 M/kg of Fentanyl manufactured by Aburihan Company, after preparing the eyes and allowing access to the operation site by the surgeon, they received 0.5 mg of Atropine manufactured by Caspian Pharmaceutical Company intravenously, as well as maintenance of anesthesia using Propofol 100 mg/kg/min was administered. the patient's symptoms were measured and recorded until the end of the operation and then during recovery.
Category
Prevention

2

Description
Intervention group 2: Patients in this group after inducting of anesthesia using 5 mg/kg of Thiopental sodium manufactured by Elixir Company, an amount of 0.5 mg/kg of Atracurium manufactured by Caspian Pharmaceutical Company, and the amount of 2 M/kg of Fentanyl manufactured by Aburihan Company, after preparing the eyes and allowing access to the operation site by the surgeon, They received 3 to 5 drops of 0.5% topical Tetracaine made by Sinadaro in 4 directions on the eyeball. as well as maintenance of anesthesia using Propofol 100 mg/kg/min was administered. the patient's symptoms were measured and recorded until the end of the operation and then during recovery.
Category
Prevention

3

Description
Control group : Patients in this group after inducting of anesthesia using 5 mg/kg of Thiopental sodium manufactured by Elixir Company, an amount of 0.5 mg/kg of Atracurium manufactured by Caspian Pharmaceutical Company, and the amount of 2 M/kg of Fentanyl manufactured by Aburihan Company, after preparing the eyes and allowing access to the operation site by the surgeon, They received 3 to 5 drops of Artificial tears made by Sinadaro in 4 directions on the eyeball. as well as maintenance of anesthesia using Propofol 100 mg/kg/min was administered. the patient's symptoms were measured and recorded until the end of the operation and then during recovery.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Feyz Hospital
Full name of responsible person
Dariush Moradi Farsani
Street address
Modares St, Qods Sq
City
Isfahan
Province
Isfehan
Postal code
4487481496
Phone
+98 31 3445 2034
Email
dmoradi@med.mui.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Mansour Siavash
Street address
Hezar Jarib
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3668 0048
Email
research@mui.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Esfahan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Dariush Moradi Farsani
Position
Anesthesiologist /Faculty
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Hezar jarib
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3668 8597
Email
dmoradi@med.mui.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Dariush Moradi Farsani
Position
Anesthesiologist /Faculty
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Hezar jarib
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3668 8597
Email
dmoradi@med.mui.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Leyla Rafiei
Position
Nurse Anesthetist
Latest degree
Bachelor
Other areas of specialty/work
Anesthesiology
Street address
Hezar Jarib
City
Isfahan
Province
Isfehan
Postal code
8146713543
Phone
+98 31 3620 2020
Email
Leylarafiei943@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...